The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for his medical team. The Chase Group is pleased to announce the successful placement of their Vice President, Head of Medical Development. This experienced leader is board certified in medical oncology and radiation therapy with expertise in all phases of pharmaceutical and biologic drug development. The Vice President, Head of Medical Development will lead the development of the company’s promising pipeline in the field of CpG oligonucleotides to develop immunotherapies and new treatment options for patients with cancer. The company is energized from their recent announcement of their Initial Public Offering, the experienced team they continue to build with this critical addition, and the prospects for their drug to make a real difference for patients. Congratulations Checkmate on the successful appointment of your Head of Medical Development! The Chase Group never loses sight of the fact that our services can profoundly impact the future success of an organization and we are honored to be entrusted with such a crucial placement for Checkmate. To find out how The Chase Group can help you identify and secure high caliber leadership for your team, please contact email@example.com.